April 11, 2013
IGNITE (Identifying Genes and Novel Therapeutics to Enhance Treatment) is a project based at the Dalhousie University in Canada, that targets rare diseases with known or suspected genetic causes. Launched in October 2011 for 3 years, the project has for objectives to: “1) Discover the genes responsible for select orphan diseases in Atlantic Canada. 2) Pinpoint the molecules most likely to respond to therapeutics. 3) Identify drugs to treat these diseases. 4) Generate intellectual property for commercial licensing partnering. 5) Develop an integrated understanding of the regulations surrounding funding for orphan diseases, attitudes around genetic testing for these diseases, and best practices for providing test results.